Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patients. Dhangar S, Shanmukhaiah C, Ghatanatti J, Sawant L, et al. Leuk Res 2025;152:107679.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dhangar S, Shanmukhaiah C, Ghatanatti J, Sawant L, et al. Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patients. Leuk Res 2025;152:107679.
PMID: 40112623